A while back I grew most fascinated by the emergence of personal genomics, that is, firms offering whole (or nearly whole) gene testing to individuals via the marketplace. Such tests were, and remain, too expensive for the average bod, but the prices have been plummeting. I even tried to offer myself to a US research project whereby I’d get my genome mapped and the public would get it amongst data for analysis (that exercise went nowhere). More recently genonomics has faded for me.
Well, here’s an interesting post from one of personal genomic’s assiduous and astute chroniclers, Daniel MacArthur at Genetic Future. Check out ‘Where to next for personal genomics?’ about sudden regulatory interest in this field in the United States.